Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
ANTX holding history
AN2 Therapeutics, Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ANTX overviewAll 13F holders of ANTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −24,168−100.0% | Sold out | Holders |
| Q1 2026 | 24,168 | $82.7K | <0.1% | +13,984+137.3% | Added | Holders |
| Q4 2025 | 10,184 | $11.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 10,184 | $12.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 10,184 | $10.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 10,184 | $13.8K | <0.1% | −10.0% | Reduced | Holders |
| Q4 2024 | 10,185 | $14.1K | <0.1% | +10,185 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −10,186−100.0% | Sold out | Holders |
| Q2 2024 | 10,186 | $21.9K | <0.1% | −40,179−79.8% | Reduced | Holders |
| Q1 2024 | 50,365 | $163.7K | <0.1% | −21,843−30.3% | Reduced | Holders |
| Q4 2023 | 72,208 | $1.48M | <0.1% | +72,208 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −18,361−100.0% | Sold out | Holders |
| Q2 2023 | 18,361 | $156.1K | <0.1% | +18,361 | New | Holders |